I asked Claude to apply a capital cycle analysis to $MU. Here's what it came up with:
Net reading: 11 of 14 capital cycle signals are bearish or strongly bearish. The framework reads this as late-cycle, not early/mid-cycle. The two unambiguously bullish signals (equipment lead times, industry concentration) are eroding rather than strengthening.
Insights Yielded by Capital Cycle Analysis:
1) "Structural change" rhetoric is itself diagnostic. The capital cycle framework treats coordinated industry-wide CEO claims of regime change as evidence of late-cycle euphoria. The same language was deployed by the same CEOs (Mehrotra at Micron specifically) in 2017–2018 and was wrong. Bayesian base rates argue against accepting the current claims at face value. The previous analysis under-weighted this base-rate evidence.
2) Look at total capital flowing into the supply curve, not just incumbent capex. The structural-change analysis focused on Big Three capex. The capital cycle lens forces aggregation of all capital flowing into memory output:
a) Incumbent capex: ~$104B in 2026 across DRAM + NAND;
b) CXMT IPO proceeds: ~$4.2B (with state-aligned co-financing many multiples larger);
c) YMTC capacity additions (privately financed)
d) Substitute technology capital (Cerebras, photonic startups, CXL controller designers) — billions of dollars of equity raised to reduce HBM intensity per dollar of AI compute deployed.
When aggregated, total effective supply-side capital formation in 2026 is materially higher than the Big Three capex alone suggests. The supply response is being underestimated.
3) The customer base is doing exactly what late-cycle customers do. Hyperscalers locking in 3–5 year LTAs, pre-ordering 2027 NAND, building strategic inventory — these are not signs of confident long-cycle visibility, they are signs of late-cycle scarcity panic. Historically (DRAM 2017–2018, oil 2008, shipping 2007), customer pre-buying at peak prices is followed by sharp inventory destocking when prices roll over. The structural-change narrative frames LTA penetration as a benefit; the capital cycle frames it as a peak signal.
4) Multiple expansion + earnings expansion = asymmetric downside. The previous analysis flagged the 15x NTM P/E multiple as aggressive (referring to UBS PT raise). The capital cycle framework sharpens this: when both earnings and multiple are at peak, the compound drawdown when either reverts is severe. Memory historically goes from 60% gross margin to negative gross margin and from 10x P/E to <5x P/E. Even a modest reversion to 35% gross margin and 8x P/E from current levels implies a 60–75% equity drawdown for the memory primaries — without any disorderly cycle.
5) Supply lag is real but not unique. The bullish point about EUV/TSV/hybrid bonding lead times is correct but mis-weighted. The capital cycle history of other capital-intensive industries (oil refining, shipbuilding, semiconductor wafer fab) shows that long lead times increase the eventual amplitude of the down-cycle: capital decisions made at peak are not reversible when conditions soften, leading to capacity overhang. Long lead times delay the down-cycle; they do not abolish it.
6) China is the textbook capital-cycle disruptor. In Chancellor's historical case studies (steel, shipbuilding, solar, panels, batteries), state-backed Chinese entrants repeatedly compressed margins of consolidated Western/Korean/Japanese oligopolies once technology gaps narrowed. The U.S. equipment restrictions on China have created the illusion that this dynamic is paused, but the data shows CXMT doubled DRAM share in 18 months and is targeting domestic HBM3. The structural-change analysis appropriately flagged this; the capital cycle framework would weight it heavier as the single most important multi-year risk.
7) Substitute capital formation is its own supply curve. The capital cycle framework treats financing flows into substitutes as a parallel supply expansion. Cerebras' $5.5B IPO, Marvell's $5B Celestial acquisition, the Sandisk/SK hynix HBF JV, and the CXL ecosystem (ALAB, MRVL, MCHP) are collectively financing "HBM intensity reduction." Even if HBM unit demand is met, the value capture per dollar of AI compute is diluted. Capital is flowing in adjacent to the memory primaries to reduce the share of AI spend that ends up in their P&L.
8) The bull case relies disproportionately on demand visibility. The capital cycle warns against demand-anchored theses. The bull case requires AI capex to continue at current levels or accelerate, hyperscaler ROI economics to remain favorable, sovereign AI to scale, and inference workloads not to migrate to non-HBM architectures. Each of these is plausible; the joint probability that all hold through 2028 is materially lower than the headline narrative suggests.
9) Sell-side estimate trajectory is itself a signal. UBS's PT trajectory ($535 → $1,625, a 3x increase in one revision) is historically associated with peak euphoria. Estimate revisions of this magnitude have a poor forward record. The framework would treat the velocity of estimate revisions as a contra-signal.
10) Where the asymmetry sits. The capital cycle framework reframes the risk/reward calculation. Even if the bull thesis is right and earnings hold through 2028, the upside from current levels is modest (multiple expansion has already happened). If the bull thesis is partially wrong — say, 2028 brings 25% peak-to-trough EPS decline rather than 50% — the equity drawdown is still material because multiples will compress simultaneously. The asymmetry is not favourable at current valuations.
Bottom line: The structural change thesis was directionally correct but materially overweighted by the original analysis. The capital cycle framework appropriately reweights toward supply-side caution and treats current peak conditions, peak valuations, peak management confidence, and accelerating capital inflows as a coherent set of late-cycle signals. The memory industry has undergone real and beneficial structural change in shape, but the empirical base rate against the "cycle has been abolished" claim is overwhelming. The economic characteristics of memory businesses have improved but have not been transformed into stable, compounding, low-volatility ones — and the next 18–30 months are statistically more likely to mark the end of this up-cycle than a transition to a new regime.
显示更多
美光今天爆涨,核心原因之一是UBS把美光的评级估值直接调高到目标价 $1635!
所以我仔细看了一下UBS今天对美光大幅上调评级的报告原文,核心是估值方法的变化。
UBS此前对美光采用的是SoTP分部加总,按照P/S倍数估值。
它把美光拆成两块:HBM业务和核心DRAM+NAND业务。HBM因为受益AI服务器需求、增长更快,给更高倍数,按照2027年收入约278.9亿美元、6倍P/S估值,对应每股约132美元;核心DRAM+NAND按2027年收入约1,877亿美元、3倍P/S估值,对应每股约405美元。
两部分相加,得到原目标价535美元。这个方法的隐含逻辑是:美光仍是强周期存储公司,只是其中HBM业务更优质,所以分开给不同收入倍数。(图 1)
现在UBS改用整体P/E估值,把目标价从535美元上调到1,625美元。新方法是用约15倍NTM P/E,锚定2029年EPS约117美元,并用约12%的股权成本折现回2028年。
UBS选择2029年EPS,是因为它认为到那时模型已包含一轮温和的存储下行周期,如果美光届时仍能赚超过100美元EPS,就说明这不是单纯周期高点盈利,而是更接近“穿越周期的盈利能力”。(图 2)
估值方法转变的核心原因是LTAs,也就是长期协议。
UBS认为,新一轮增强型LTA不只是锁定出货量,还包括3到5年期限、固定量承诺和部分固定价格机制。它估计2027年行业DDR出货中约20%到30%会被这类协议覆盖,美光约20%,hyperscaler已锁定行业Server DDR5约60%到70%的量。这样一来,美光的收入和利润可见度提高,DDR价格峰谷波动可能被压低约一半。
所以,UBS的判断是:美光不再只是靠存储价格周期上行赚钱的公司,而是因为AI需求和长期锁价锁量协议,盈利稳定性被系统性抬高。
因此估值框架从“分部收入倍数”切换为“整体盈利倍数”。核心变化就是从“HBM单独重估”升级为“美光整体重估”。
显示更多